BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

U.S. RENAL CARE — Lobbying — Receipts Report

LD-2 disclosure · 4th Quarter - Report

U.S. RENAL CARE

via WELSH ROSE, LLC

4th Quarter (Oct 1 - Dec 31) · 2025Posted Jan 16, 2026Filing document ↗LDA record ↗

Income$50Kfee reported

Client

Name: U.S. RENAL CARE
Description: Provider of dialysis services.
Location: Texas · United States of America

Registrant

Firm: WELSH ROSE, LLC
Description: Consulting firm.
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Medicare/Medicaid
Dialysis reimbursement issues and issues related to the Medicare Secondary Payer program.
LobbyistsKATE ROSE
TargetedSENATE · HOUSE OF REPRESENTATIVES · Centers For Medicare and Medicaid Services (CMS)

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.